Arbekacin as an Alternative Drug to Teicoplanin for the Treatment of MRSA Infection

키워드

참고문헌 (10)

1. Miller CE, "An association between bacterial genotype combined with a highvancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection", Clin Infect Dis, 54, pp.591~600 (2012)
2. Ida T, "Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan", J Clin Microbiol, 39, pp.3115~3121 (2001)
3. Watanabe T, "Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus", J Antimicrob Chemother, 39, pp.471~476 (1997)
4. Hwang JH, "The usefulness of arbekacin compared to vancomycin", Eur J Clin Microbiol Infect Dis, 31, pp.1663~1666 (2012)
5. 황지희, "The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study", Infection and Chemotherapy, 45(1), pp.62~68 (2013), 대한감염학회[DOI]
6. Manjunath G, "Prediction equations to estimate glomerular filtration rate: an update", Curr Opin Nephrol Hypertens, 10, pp.785~792 (2001)
7. Mumoli N, "Drug-related hepatotoxicity", N Engl J Med, 354, pp.2191~2193 (2006)
8. Hochberg MC, "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 40, pp.1725~ (1997)
9. 김태형, "메티실린 내성 포도구균(MRSA) 감염에 대한 Arbekacin의임상적 효과 및 안전성", 대한내과학회지, 65(2), pp.239~244 (2003), 대한내과학회
10. 황지희, "Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus", Journal of Korean Medical Science, 30(6), pp.688~693 (2015), 대한의학회

관련 논문AI추천